Biomea Fusion
Price & Volume
Stats
See moreOpen | $6.24 |
Previous Close | $6.38 |
Day Range | $6.23-$6.63 |
52W Range | $3.61-$22.74 |
Market Cap | $227.5M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.01 |
News
See moreYahoo Finance • 12 months ago
Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024
Yahoo Finance • last year
Biomea Fusion to Present New Data from Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes at the World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Yahoo Finance • last year
Biomea Fusion Announces Two Poster Presentations at Upcoming ASH Annual Meeting 2023
About
CEO | Mr. Thomas Andrew Butler |
Address | 900 Middlefield Road, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 107 |
